Bessemer made significant AI investments in 2024-2025, including Anthropic's $4.5B Series E, Perplexity AI's $73.6M Series B, and Abridge's healthcare AI rounds ($150M Series C, $250M Series D). The firm published "Everything, Everywhere, All AI" (2024) outlining ethical AI investment strategy. Bessemer's healthcare AI road map identified six priority areas including evaluation infrastructure and specialty foundation models. The firm views personal AI agents as "arguably the most important next category in AI."
All receipts on Bessemer Venture Partners
Bessemer Venture Partners
Bessemer long-term focus. Anti-portfolio honesty. Less aggressive restructuring.
Share this receipt
Posts with the receipt card attached.
Post this receiptDownload card
Bessemer Venture Partners — Worker Treatment: MIXED Bessemer long-term focus. Anti-portfolio honesty. Less aggressive restructuring. https://reciepts.tech/stance/747